Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Self-Monitoring Blood Glucose (SMBG) Devices Market Growth From $17.56 Billion In 2026 To $24.17 Billion By 2030 At A CAGR Of 8.3%
The self-monitoring blood glucose (smbg) devices market has experienced significant growth in recent years. It is anticipated to expand from $16.19 billion in 2025 to $17.56 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.5%. The historical rise of this market can be linked to the increasing prevalence of diabetes, a growing understanding of self-monitoring practices, the broader adoption of home healthcare, the accessibility of affordable glucose meters, and improved diabetes management guidelines.
The self-monitoring blood glucose (SMBG) devices market size is anticipated to undergo substantial expansion in the coming years. This market is forecast to grow to $24.17 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%. The drivers for this growth during the forecast period include an escalating demand for connected health solutions, increased adoption of continuous glucose monitoring, the broadening of telehealth-based diabetes care, a heightened emphasis on preventive healthcare, and growing investments in digital diabetes management. Key trends expected in this period encompass the rising uptake of smart glucose monitoring devices, the expanding utilization of continuous glucose monitoring systems, the increasing integration of mobile health applications, the extension of remote patient monitoring solutions, and an enhanced focus on designing patient-friendly devices.
Get A Free Sample Report With In-Depth Market Insights:
Self-Monitoring Blood Glucose (SMBG) Devices Market Growth Factors: What’s Supporting Expansion?
The growing incidence of diabetes is anticipated to fuel the expansion of the self-monitoring blood glucose device market in the coming years. Diabetes is defined as a chronic metabolic condition where the body either fails to produce sufficient insulin or cannot effectively utilize it, leading to elevated blood glucose levels that can harm various organs and systems over time. This increase in diabetes prevalence mainly stems from unhealthy eating habits, which incrementally raise long-term blood sugar levels and gradually impair metabolic health. Self-Monitoring Blood Glucose (SMBG) Devices assist in managing diabetes by allowing individuals to monitor their real-time blood sugar levels, facilitating prompt adjustments in diet, medication, or physical activity to achieve superior glycemic control. For instance, in June 2024, the National Health Service, a UK-based government body, reported that in 2023, the NHS identified an additional over half a million (549,000) people in England susceptible to developing type 2 diabetes. This pushed the total count of individuals with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP, to 3,615,330. This figure signifies a substantial rise compared to 3,065,825 in 2022, indicating an increase of nearly 20%. Consequently, the escalating prevalence of diabetes is propelling the growth of the self-monitoring blood glucose devices market.
Self-Monitoring Blood Glucose (SMBG) Devices Market Segment Outlook: Which Categories Are Growing Fastest?
The self-monitoring blood glucose (smbg) devices market covered in this report is segmented –
1) By Product: Self-Monitoring Blood Glucose Meters, Testing Strips, Lancets
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Sales, Diabetes Clinics & Centers
3) By Application: Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes
Subsegments:
1) By Self-Monitoring Blood Glucose Meters: Traditional Glucose Meters, Smart Glucose Meters
2) By Testing Strips: Standard Testing Strips, Test Strips for Specific Meters
3) By Lancets: Standard Lancets, Safety Lancets
Self-Monitoring Blood Glucose (SMBG) Devices Market Industry Trends: What’s Reshaping Demand?
Leading companies in the self-monitoring blood glucose (SMBG) devices market are prioritizing the development of innovative solutions, such as continuous glucose monitoring (CGM) systems, to address the increasing need for less burdensome glucose tracking, improved glycemic management, remote patient monitoring, and better compatibility with insulin delivery and digital health platforms. CGM systems are wearable sensors that continuously measure interstitial glucose, providing trend data, alerts, and cloud-connected reporting; their key functionalities include real-time glucose readings, trend arrows, customizable alarms, and data sharing capabilities. Unlike traditional fingerstick SMBG (glucometers) which require discrete capillary blood samples and offer only point-in-time values, CGMs enable proactive therapy adjustments and richer longitudinal insights, thereby reducing the risk of hypoglycemia and improving time-in-range. For example, in August 2024, Medtronic plc, an Ireland-based medical technology company, introduced Simplera CGM, a compact, disposable, all-in-one continuous glucose monitor designed for easier self-application, real-time glucose sensing, and seamless operation with both the InPen smart insulin pen and the MiniMed 780G system, offering users a smaller form factor, simplified wear, and enhanced interoperability that supports continuous visibility for Smart MDI users, redundant sensing for pump users, and overall improved comfort, adherence, and clinical decision-making through the integration of continuous glucose trend data.
Self-Monitoring Blood Glucose (SMBG) Devices Market Leading Players And Competitive Positioning
Major companies operating in the self-monitoring blood glucose (smbg) devices market are Abbott Laboratories, Bionime Corporation, B Braun Melsungen AG, F Hoffmann La Roche Ltd, LifeScan Inc, PHC Holdings Corporation, Home Diagnostics Inc, ARKRAY Inc, Ypsomed Holding AG, Dexcom Inc, Medtronic plc, Senseonics Holdings Inc, AgaMatrix Inc, All Medicus Co Ltd, Ascensia Diabetes Care Holdings AG, Bayer AG, Becton Dickinson and Company, Cnoga Medical Ltd, ForaCare Inc, Infopia Co Ltd, Menarini Diagnostics, Nipro Corporation, Nova Biomedical Corporation, Omron Healthcare Inc, OrSense Ltd, Prodigy Diabetes Care LLC, PTS Diagnostics, TaiDoc Technology Corporation, Trividia Health Inc
View The Full Self-Monitoring Blood Glucose (SMBG) Devices Market Report:
Self-Monitoring Blood Glucose (SMBG) Devices Market Regional Split: Which Areas Are Fueling Growth?
North America was the largest region in the self-monitoring blood glucose (SMBG) devices market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the self-monitoring blood glucose (smbg) devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
